Search
for
Sort by
Research 30 of 1000+
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy
- Clinical response and time to improvement with 308-nm excimer laser therapy in scarring alopecia: a retrospective cohort study
- Assessment of Dysregulation of HERC6 and Essential Biological Processes in Response to Laser Therapy of Human Arm Skin
- Clinical Response to Combined Therapy of Cyclosporine and Prednisone
- Response to: “Rethinking biotin therapy for hair, nail, and skin disorders”
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- 224 Humoral immune response to COVID-19 vaccination in psoriasis patients on biologic therapy is impaired compared to healthy controls
- Effectiveness and Predictive Factors of Response to Tofacitinib Therapy in 125 Patients with Alopecia Areata: A Single-centre Real-world Retrospective Study
- Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin
- Response to Kang et al, “Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: A retrospective cohort study”
- Back to the Basics: Response of Alopecia Areata Universalis to Intravenous High-Dose Pulse Corticosteroid Therapy
- 878 Individual variation in balance between platelet-secreted growth factors causing contradictory effects on hair follicle could potentially impact response to PRP therapy in patients with scalp hair loss
- Do clinical markers of hyperandrogenism relate to the response of acne to conventional therapy?
- Objective and Subjective Assessments of the Response of Photobiomodulation Therapy Against Alopecia Areata
- Reply to: “Response to ‘Rethinking biotin therapy for hair, nail, and skin disorders’”
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Adjunctive Dupilumab Therapy in a Partial Responder to Baricitinib for Alopecia Areata
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Pemphigus Vulgaris Lacking Mucosal Involvement in a German Shepherd Dog: Possible Response to Heparin Therapy
- Dose-Response Overstatement and Vesicle-Attribution Uncertainty in Hypoxia-Conditioned MSC Exosome Therapy for Androgenetic Alopecia
- Predictive value of the serum albumin change rate for therapeutic response to targeted therapy in patients with AIDS-related non-Hodgkin lymphoma
- Pediatric Discoid Lupus Erythematosus with Scalp-Exclusive Involvement: Trichoscopy and Response to Early Minipulse Corticosteroid Therapy
- Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials
- Letter in response to “The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia”
- Label-free multiphoton imaging to assess neoadjuvant therapy responses in breast carcinoma
- Ichthyosis linearis circumflexa in a child. Response to narrowband UVB therapy.
- Efficacy and predictive markers of response to tofacitinib and baricitinib therapy in alopecia areata: A 52-week comparative cohort study
- Response to microneedling treatment in men with androgenetic alopecia who failed to respond to conventional therapy
- <i>NIPAL4</i> deletion identified in an American Bully with autosomal recessive congenital ichthyosis and response to topical therapy